EDGAR Filing Documents for 0001193125-12-191538

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]

SEC Accession No. 0001193125-12-191538

Filing Date

2012-04-27

Accepted

2012-04-27 17:04:09

Documents

Period of Report

2011-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	AMENDMENT NO. 1 TO FORM 10-K	d340364d10ka.htm	10-K/A	808663
2	JAZZ PHARMACEUTICALS PLC CASH BONUS PLAN	d340364dex1033.htm	EX-10.33	23629
3	AMENDED AND RESTATED EXECUTIVE CHANGE IN CONTROL AND SEVERANCE BENEFIT PLAN	d340364dex1034.htm	EX-10.34	112062
4	CERTIFICATION OF CEO PURSUANT TO RULES 13A-14(A) AND 15D-14(A)	d340364dex313.htm	EX-31.3	3758
5	CERTIFICATION OF CFO PURSUANT TO RULES 13A-14(A) AND 15D-14(A)	d340364dex314.htm	EX-31.4	3763
	Complete submission text file	0001193125-12-191538.txt		952947

Mailing Address 45 FITZWILLIAM SQUARE DUBLIN L2 2

Business Address 45 FITZWILLIAM SQUARE DUBLIN L2 2 353-1-634-4183

Jazz Pharmaceuticals plc (Filer) CIK: 0001232524 (see all company filings)